4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-25-097007
Options or other derivatives
- Chief Commercial Officer acquired 51,255 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Friedl-Naderer Johanna Chief Commercial Officer | 2025-07-16 | Grant or award · Stock option (right to buy) | +51,255 | 51,255 | D: show line 1 in the form |
Loading xslF345X05/ownership.xml…